#Italy #Milan #MGI Tech #STOmics #Go Spatial

MGI Tech Launches Go Spatial in Europe

MGI Tech Co., Ltd., a leading name in life sciences technology, has recently introduced its innovative product, Go Spatial, at the STOC General Meeting 2026 held in Milan, Italy. This launch marks a significant step towards enhancing the accessibility and efficiency of spatial transcriptomics in Europe, as well as expanding the company's partnership network with the addition of Omics Empower GmbH as a certified STOmics service provider.

Introducing Go Spatial

Go Spatial is an automated workflow designed specifically for spatial transcriptomics, making high-resolution tissue research more accessible to scientists and researchers. This innovation is built on MGI's advanced Stereo-seq technology, which permits high-resolution spatial analysis across a variety of biological fields including oncology, neuroscience, and immunology. This technology allows researchers to analyze centimeter-scale fields of view and process significant amounts of tissue samples per day: up to 12 cm² of fresh frozen tissue or eight cm² of formalin-fixed, paraffin-embedded (FFPE) tissue.

One of the standout features of Go Spatial is its capability to simplify the post-imaging sample preparation process, converting RNA captures to cDNA with minimal hands-on intervention. This level of automation not only streamlines data collection but also enhances the reliability and reproducibility of results, which are crucial in life sciences research.

Expanding the STOmics Partner Network

At the STOC 2026, MGI Tech also introduced new products tailored for advancing spatial transcriptomics research. Notably, StereoLink and Stereo-seq OMNI Large Chip Design for FFPE samples were highlighted. StereoLink enhances the workflow by facilitating a smoother transfer of tissues onto Stereo-seq chips, while the Stereo-seq OMNI Large Chip Design expands spatial analysis capabilities, enabling researchers to profile larger and more intricate tissue samples efficiently.

In a strategic move, MGI Tech has welcomed Omics Empower GmbH as a new addition to its STOmics network. This partnership significantly boosts localized access to STOMics-powered spatial transcriptomics services across Europe, particularly with a focus on advanced applications such as Stereo-seq OMNI V1.1. By operating lab facilities in Berlin, both organizations aim to establish a dedicated STOmics service hub in Europe, thereby improving research accessibility and turnaround times.

Supporting European Researchers

The collaboration with Omics Empower is not just about increasing service capacity; it embodies MGI's commitment to fostering a more collaborative environment for researchers. Yang Liu, the Managing Director at Omics Empower, expressed enthusiasm about this strategic partnership, emphasizing the potential to deliver high-quality localized services that can drive scientific innovation across Europe.

Vice President of MGI, Fang Chen, highlighted the significance of STOC 2026 as a platform for uniting the global spatial biology community, stating, “With Go Spatial and Omics Empower as a new STOmics certified service provider, MGI is strengthening both the technology and service ecosystem for spatial transcriptomics in Europe.”

Future Aspirations

The STOC General Meeting aims to facilitate concrete actions that align scientific goals with collaborative projects and funding opportunities in the rapidly evolving field of spatio-temporal omics. MGI Tech's ongoing commitment to integrating spatial transcriptomics into its multi-omics offerings showcases its dedication to advancing the scientific community's capabilities.

Following its acquisition of STOmics earlier this year, MGI continues to pave the way for enhanced technology ecosystems across Europe, with the goal of broadening the accessibility of spatial transcriptomics. MGI's strategies, including the introduction of Go Spatial and strengthened partnerships, are set to play a crucial role in accelerating scientific discoveries in life sciences.

About MGI Tech

Founded in 2016, MGI Tech Co., Ltd. has rapidly emerged as a leader in the life science sector. The organization focuses on developing essential tools and technologies that foster innovation across various fields, including biotechnology and precision medicine. MGI provides an extensive range of solutions from real-time multi-omics to advanced digital equipment, and its commitment to quality and global impact continues to shape the future of life sciences.

To keep abreast of their latest developments, visit the MGI Tech website, or connect with them on LinkedIn, X, Instagram, and YouTube.

About Omics Empower

Omics Empower GmbH specializes in multi-omics technologies, delivering expert services in single-cell and spatial omics, next-generation sequencing, and bioinformatics analysis. With a track record of contributing to over 500 peer-reviewed research publications, Omics Empower strives to empower researchers and advance biotechnological applications in the life sciences.